OOwkin logo

Owkin

Unclaimed
BiotechnologySoftware + Servicesowkin.comUpdated

Owkin applies agentic AI and patient data to advance biological research and help develop new treatments and diagnostics.

Overview

Owkin is an agentic AI company focused on solving complex problems in biology. It combines multimodal patient data, advanced AI, biomedical expertise, and laboratory validation to support pharmaceutical research teams in discovering treatments and improving research and clinical decision-making.

Mission statement

To explore complex biology and speed up and scale research for the creation of new treatments and diagnostics for patients.

One of 16 AI agents in Biotechnology

Read recently by Meta

What we offer

K Pro

Helps biopharma teams analyze patient data, test biological hypotheses, and make informed decisions across drug discovery and development.

owkin.com →

Patient data access

Service

Helps researchers find research-ready patient cohorts and multimodal data suited to their scientific questions, with support from Owkin’s data network team.

owkin.com →

MOSAIC

Supports oncology research into target discovery, validation, and ADC design with spatial and multi-omic detail of cancer biology.

owkin.com →

Pathology Explorer

Helps users explore histology data conversationally and identify cell types and tissue structures automatically.

owkin.com →

More information about our offering

K Pro

K Pro is an AI scientist for biology and biopharma R&D. It combines multimodal patient data, specialized biomedical skills, tools, and AI reasoning in an agentic platform that supports work across drug discovery and development. Users can ask questions in natural language, generate and test hypotheses, analyze patient populations, and produce publication-ready reports. K Pro supports human-led analysis and autonomous research campaigns, integrates with enterprise systems, and can be accessed as SaaS or deployed on a client’s infrastructure. Its analyses can be informed by clinical and laboratory validation.

  • Coordinate Specialized Research Capabilities
    Work through one agent that chooses which expert skills and tools to activate, rather than managing multiple separate tools.
  • Analyze Real-World Patient Data
    Ground biological research in patient data across modalities, helping teams investigate disease biology and identify treatment hypotheses.
  • Repeat Analyses With Greater Consistency
    Apply defined analytical procedures to help produce consistent, traceable results that scientists can review and defend.
  • Get Research Answers In Minutes
    Ask scientific questions directly and receive analyses and answers without having to coordinate separate tools for each step.
  • Define Patient Populations
    Characterize patient subgroups and identify biomarkers that can help teams refine populations for research and clinical trials.
  • Test Biomarkers Across Data Modalities
    Examine whether biomarkers and biological hypotheses are supported across multiple data types, including spatial and clinical data.
  • Connect Biology To Clinical Outcomes
    Bring molecular and clinical evidence together to investigate therapeutic opportunities and treatment response.
  • Test Hypotheses Against Experimental Results
    Connect AI-generated biological hypotheses with laboratory experiments, using experimental findings to validate predictions and inform subsequent analyses.
  • Prioritize Targets With Statistical Evidence
    Compare target and gene candidates using statistical evidence to support target discovery and research prioritization.
  • Assess Target Developability
    Review target tractability, safety profiles, and therapeutic potential to inform research and early portfolio decisions.
  • Explore Research Questions In Parallel
    Run independent research work on multiple aspects of a question concurrently through autonomous sub-agents.
  • Guide Or Delegate Research Analysis
    Use K Pro as a research copilot for human-led work or run self-driven campaigns to generate, test, and prioritize hypotheses.
  • Connect K Pro To Existing Systems
    Integrate K Pro with enterprise data systems, APIs, and existing workflows rather than replacing those systems.
  • Deploy Within Your Chosen Environment
    Choose SaaS access or deployment on client infrastructure behind a selected firewall, with stated ISO 27001 and GDPR compliance.
  • Adapt Research Skills To Your Work
    Use expert-built, customizable skills to shape analyses around specific research goals, procedures, and desired outputs.
  • Generate Publication-Ready Reports
    Create structured statistical reports to support target assessment, biomarker prioritization, and patent landscape analysis.
  • Execute Generated Programs In A Sandbox
    Address tasks without predefined procedures by generating programs for execution in a sandboxed environment.

Patient data access

Access Owkin’s multimodal patient data through curated, ready-made cohorts or cohorts scoped around a research question. The data network team helps identify the cohort and modalities needed, drawing on data from 166 partner institutions and representing more than 24.5 million patients. Data products include clinical and imaging data, with additional molecular, single-cell, and spatial data capabilities. Data is curated, structured, and quality-control validated for research and AI model training.

  • Explore Matched Multimodal Data
    Bring together matched patient data across clinical and other available modalities to explore research questions using more than one type of information.
  • Use Structured, QC-Validated Data
    Work with curated, structured data that has been quality-control validated and prepared for research and AI model training.
  • Build Cohorts Around Research Questions
    Work with Owkin’s data team to scope a cohort and identify the data modalities needed for a specific research question.
  • Access Curated Patient Cohorts
    Explore ready-made cohorts organized by indication and arrange access with Owkin’s data network team.
  • Access Data Across A Broad Network
    Draw on a network of academic and clinical partners representing more than 24.5 million patients across 23 indications.
  • Support Privacy-Conscious Research
    Access data within a service that describes privacy, security, and data protection safeguards, including pseudonymization or de-identification before access.
  • Retain Patient Journey Context
    Use patient-centred data with treatment-path labels and retained context to interpret research data in relation to the patient journey.
  • Source Consent-Verified Data
    Access data described as consent-verified and quality-control validated, sourced through Owkin’s academic and clinical partner network.
  • Get Support Scoping Data Needs
    Work with Owkin’s data network team to define the cohort and modalities required for research, with K Pro support throughout.
  • Access Retained Samples
    Use data products that may include retained sample access, as identified among the characteristics of Owkin’s data.

MOSAIC

MOSAIC is Owkin’s spatial multiomics dataset in oncology, described as the world’s largest spatial multiomics dataset in the field. It provides tumor biology in its full tissue context and is available to license through K Pro. Owkin materials describe using MOSAIC for target discovery and validation, ADC design, and research into intra-tumoral heterogeneity through large-scale spatial and cell-resolved multi-omics profiling.

  • Explore Cancer Biology In Tissue Context
    Examine spatial and cell-resolved multi-omics information while retaining the tumor’s tissue context.
  • Characterize Intra-Tumoral Heterogeneity
    Use spatial and cell-resolved multi-omics profiling to investigate variation within tumors.
  • Find And Validate Oncology Targets
    Support oncology target research with spatial multiomics data that can help investigate candidate targets in tumor context.
  • Inform Smarter ADC Design
    Use MOSAIC for oncology research into ADC design, including analysis of response- and toxicity-related hallmarks.
  • Access MOSAIC Through K Pro
    License and analyze the MOSAIC dataset through Owkin’s K Pro environment.

Pathology Explorer

Pathology Explorer is a specialized biological AI agent for working with histology data. It automatically detects cell types and tissue structures from histology data and lets users converse directly with histological data. Its model is available in Claude for Life Sciences through MCP.

  • Detect Cell Types And Tissue Structures
    Automatically identifies cell types and tissue structures in histology data, helping users examine tissue information.
  • Explore Histology Data Conversationally
    Lets users interact with histological data through conversation, providing a direct way to explore the data.
  • Access Pathology Explorer Through Claude
    Makes the Pathology Explorer model available in Claude for Life Sciences via MCP.

Sources

Methodology and sourcing behind the figures and links shown above.

Behind this page

This is a public preview. Whoever claims it decides what it shows.

This page was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention Owkin, where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks Owkin higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the page is listed at all. Unlisting takes one switch.

Built from public web sources. Request removal →